Effect of polyanion-resistance on HIV-1 infection

被引:19
作者
Bobardt, MD
Armand-Ugón, M
Clotet, I
Zhang, Z
David, G
Este, JA
Gallay, PA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Hosp Germans Trias & Pujol, Retrovirol Lab IrsiCaixa, Badalona 08916, Spain
[3] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[4] Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium
关键词
polyanion; HIV-1; T cell;
D O I
10.1016/j.virol.2004.05.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically.. a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1-HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This reinforces the hypothesis that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 41 条
[1]   Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts [J].
Argyris, EG ;
Acheampong, E ;
Nunnari, G ;
Mukhtar, M ;
Williams, KJ ;
Pomerantz, RJ .
JOURNAL OF VIROLOGY, 2003, 77 (22) :12140-12151
[2]   SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
BABA, M ;
SNOECK, R ;
PAUWELS, R ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745
[3]   ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF SULFATED MONOSACCHARIDES - COMPARISON WITH SULFATED POLYSACCHARIDES AND OTHER POLYIONS [J].
BAGASRA, O ;
WHITTLE, P ;
HEINS, B ;
POMERANTZ, RJ .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1082-1090
[4]   Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding [J].
Basmaciogullari, S ;
Babcock, GJ ;
Van Ryk, D ;
Wojtowicz, W ;
Sodroski, J .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10791-10800
[5]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[6]   Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion [J].
Bobardt, MD ;
Salmon, P ;
Wang, LC ;
Esko, JD ;
Gabuzda, D ;
Fiala, M ;
Trono, D ;
Van der Schueren, B ;
David, G ;
Gallay, PA .
JOURNAL OF VIROLOGY, 2004, 78 (12) :6567-6584
[7]   Syndecan captures, protects, and transmits HIV to T lymphocytes [J].
Bobardt, MD ;
Saphire, ACS ;
Hung, HC ;
Yu, XC ;
Van der Schueren, B ;
Zhang, Z ;
David, G ;
Gallay, PA .
IMMUNITY, 2003, 18 (01) :27-39
[8]   DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[9]   Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor [J].
Derdeyn, CA ;
Decker, JM ;
Sfakianos, JN ;
Zhang, ZJ ;
O'Brien, WA ;
Ratner, L ;
Shaw, GM ;
Hunter, E .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8605-8614
[10]   The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication [J].
DeVreese, K ;
KoflerMongold, V ;
Leutgeb, C ;
Weber, V ;
Vermeire, K ;
Schacht, S ;
Anne, J ;
DeClercq, E ;
Datema, R ;
Werner, G .
JOURNAL OF VIROLOGY, 1996, 70 (02) :689-696